retatrutide clinical trials countries Phase 3: TRIUMPH Program Results 2026 Retatrutide UK | The Ultimate

What retatrutide is actually called Retatrutide is the official generic name, assigned by the World Health Organisation through its International Nonproprietary Names (INN) programme

Its design includes a fatty acid side chain (C-18 fatty di-acid) that allows it to bind to albumin in the blood, extending its half-life

Miyata 2015

Real outcome data comes from clinical trials and verifiable patient records, not marketing carousels

Coherentemente, los datos obtenidos en estudios realizados en modelos in vivo de isquemia-reperfusin y de IC demuestran que la activacin de la va RISK mediada por GLP-1 incrementa la supervivencia del miocardio (tabla 2)